Tammy Romo Sells 4,922 Shares of Tenet Healthcare (NYSE:THC) Stock

Tenet Healthcare Corporation (NYSE:THC) Director Tammy Romo sold 4,922 shares of the company’s stock in a transaction that occurred on Thursday, August 6th. The stock was sold at an average price of $264.15, for a total value of $1,300,146.30. Following the transaction, the director directly owned 30,784 shares of the company’s stock, valued at approximately $8,131,593.60. The trade was a 13.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Tammy Romo also recently made the following trade(s):

• On Friday, August 7th, Tammy Romo sold 2,500 shares of Tenet Healthcare stock. The shares were sold at an average price of $260.83, for a total transaction of $652,075.00.

Tenet Healthcare Stock Performance

NYSE:THC opened at $259.74 on Wednesday. The stock has a market capitalization of $20.91 billion, a PE ratio of 10.02, a P/E/G ratio of 0.99 and a beta of 1.23. The company has a fifty day moving average of $203.92 and a two-hundred day moving average of $202.38. The company has a debt-to-equity ratio of 2.00, a quick ratio of 1.35 and a current ratio of 1.41. Tenet Healthcare Corporation has a fifty-two week low of $157.58 and a fifty-two week high of $265.32.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 earnings per share for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm had revenue of $6.04 billion for the quarter, compared to analyst estimates of $5.43 billion. During the same period last year, the company posted $4.02 EPS. Tenet Healthcare’s quarterly revenue was up 6.8% compared to the same quarter last year. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, research analysts forecast that Tenet Healthcare Corporation will post 21.09 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of THC. NewEdge Advisors LLC lifted its stake in Tenet Healthcare by 6.1% during the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock worth $389,000 after acquiring an additional 166 shares in the last quarter. Jones Financial Companies Lllp grew its holdings in shares of Tenet Healthcare by 299.1% in the first quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock valued at $229,000 after purchasing an additional 1,274 shares in the last quarter. Sivia Capital Partners LLC acquired a new stake in Tenet Healthcare during the 2nd quarter worth approximately $290,000. Quantbot Technologies LP acquired a new position in shares of Tenet Healthcare in the second quarter worth $65,000. Finally, Amundi raised its stake in shares of Tenet Healthcare by 4,207.8% in the second quarter. Amundi now owns 27,010 shares of the company’s stock valued at $4,652,000 after acquiring an additional 26,383 shares in the last quarter. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several analysts recently issued reports on THC shares. Truist Financial upped their price objective on shares of Tenet Healthcare from $270.00 to $290.00 and gave the company a “buy” rating in a research note on Tuesday, July 28th. Mizuho set a $290.00 target price on Tenet Healthcare in a report on Monday. Royal Bank Of Canada boosted their price target on shares of Tenet Healthcare from $236.00 to $283.00 and gave the company an “outperform” rating in a research report on Monday, July 27th. The Goldman Sachs Group reissued a “buy” rating and issued a $305.00 price target on shares of Tenet Healthcare in a research note on Tuesday, July 28th. Finally, Morgan Stanley raised their target price on Tenet Healthcare from $254.00 to $274.00 and gave the stock an “overweight” rating in a research note on Monday, July 27th. Seventeen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $272.25.

About Tenet Healthcare

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.